Ectycell Folded into Cellectis bioresearch | GenomeWeb

NEW YORK (GenomeWeb News) – Cellectis Group today announced that its stem cell business unit Ectycell has merged with Cellectis bioresearch.

Cellectis Group also announced a €3.5 million ($4.1 million) capital increase into Cellectis bioresearch, which was subscribed for by French financial organization Caisse des Depots.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.